Find your next paid study

Ambros Therapeutics, Inc.NCT07210515

Phase 2

Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)

This study evaluates the rates of radiation-specific toxicity, quality of life, and oncologic outcomes for early-stage breast cancer and ductal carcinoma in si…

Breast CancerEarly-stage Breast CancerDuctal Carcinoma in Situ+1 more

UNC Lineberger Comprehensive Cancer CenterNCT06902311

Observational

The Oh Happy Day Class - Digital Connections (OHDC-DC): an Exploratory Pilot Study

The goal of this clinical trial is to see if a mobile phone app can deliver depression treatment to African Americans who are depressed. The main question it a…

DepressionDepressive DisorderDepressive Symptoms

University of Wisconsin, MadisonNCT06206226

Phase 3

A Phase 3, Randomized, Double-blind, Efficacy and Safety Study Comparing Orelabrutinib to Placebo in Patients With Primary Progressive Multiple Sclerosis

Orelabrutinib is a CNS-penetrable BTK inhibitor. This is a phase 3, randomized, double-blind, parallel-group, multicenter study to evaluate the efficacy and sa…

Multiple Sclerosis (MS) Primary Progressive

Zenas BioPharma (USA), LLCNCT07067463

Phase 1

Lurbinectedin in FET-Fusion Tumors (LIFFT)

The purpose of this study is to find out if a drug called lurbinectedin (the "study drug") is safe and effective at treating people with recurrent or relapsed …

Ewing SarcomaDesmoplastic Small Round Cell TumorPediatric Cancer+1 more

Children's Hospital of PhiladelphiaNCT05918640

Observational

A Multi-Institutional Central Pathology and Molecular Risk-Based Stratification Study of Surgical Management for Melanoma, Atypical Spitz/Spitzoid Tumors, and Other Atypical Melanocytic Neoplasms in Pediatric Patients

This clinical trial compares the effect of using risk-based stratification to guide surgical management to the usual approach in treating cutaneous melanoma, a…

Clinical Stage 0 Cutaneous Melanoma AJCC v8Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage II Cutaneous Melanoma AJCC v8+4 more

Children's Oncology GroupNCT07621614

~$10 – $7,500

Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Background: Neurodegenerative disorders can lead to problems in movement or memory. Some can cause abnormal proteins to build up in brain cells. Researchers w…

Frontotemporal DementiaAmyotrophic Lateral SclerosisProgressive Supranuclear Palsy

National Institute of Neurological Disorders and Stroke (NINDS)NCT03225144

~$10 – $675

Natural History of Noncirrhotic Portal Hypertension

Background: \- Noncirrhotic Portal Hypertension (NCPH) is caused by liver diseases that increase pressure in the blood vessels of the liver. It seems to start…

Cystic FibrosisImmunologic Deficiency SyndromeTurner Syndrome+2 more

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT02417740

~$10 – $675

Phase 3

A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to …

Breast Cancer

~$10 – $7,500

NRG OncologyNCT05879926

Observational

A Pivotal, Prospective, Multicenter, 2:1 Randomized, Double Blind, Controlled, Study Comparing the THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension (The THRIVE Study)

The primary objective of the THRIVE Pivotal study is to demonstrate the adjunctive effectiveness and the safety of the TIVUS system in: 1. subjects with uncon…

Hypertension

SoniVie Inc.NCT06559891

Phase 1

Sympathetic Neural Patterns and Transduction in Obesity-associated Hypertension

The purpose of this study is to understand how the nervous system communicates to blood vessels to increase blood pressure during stress. The study will also i…

HypertensionObesity

University of Texas Southwestern Medical CenterNCT04838678

Phase 2

A Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants With High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

This is a Phase 2, Multi-Arm, Multi-Cohort, Open-Label Study to Evaluate the Safety and Efficacy of Cretostimogene Grenadenorepvec in Participants with High-Ri…

High-Risk Non-Muscle-Invasive Bladder Cancer